Old Web
English
Sign In
Acemap
>
authorDetail
>
Shahriar Sedghi
Shahriar Sedghi
Medicine
Ulcerative colitis
Internal medicine
Placebo
Surgery
8
Papers
120
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
2016
Journal of Clinical Gastroenterology
Glenn L. Gordon
Salam F. Zakko
Uma Murthy
Shahriar Sedghi
Ronald E. Pruitt
Andrew C. Barrett
Enoch Bortey
Craig Paterson
William P. Forbes
Gary R. Lichtenstein
Show All
Source
Cite
Save
Citations (16)
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
2016
Postgraduate Medicine
Salam F. Zakko
Glenn L. Gordon
Uma Murthy
Shahriar Sedghi
Ronald E. Pruitt
Andrew C. Barrett
Enoch Bortey
Craig Paterson
William P. Forbes
Gary R. Lichtenstein
Show All
Source
Cite
Save
Citations (9)
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial
2015
Journal of Pediatric Orthopaedics
Glenn L. Gordon
Salam F. Zakko
Uma Murthy
Shahriar Sedghi
Ronald E. Pruitt
Andrew C. Barrett
Enoch Bortey
Craig Paterson
William P. Forbes
Gary R. Lichtenstein
Show All
Source
Cite
Save
Citations (0)
Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials
2012
Alimentary Pharmacology & Therapeutics
Gary R. Lichtenstein
Salam Zakko
Glenn L. Gordon
Uma K. Murthy
Shahriar Sedghi
Ronald Pruitt
Kunal Merchant
Enoch Bortey
William P. Forbes
Show All
Source
Cite
Save
Citations (8)
1